Medicine guide

KALETRA

As listed in the register: KALETRA 200 mg/50 mg, comprimé pelliculé

200 mg + 50 mg · comprimé pelliculé

  • Prescription only
Active substance
Lopinavir + Ritonavir
Made by
ABBVIE DEUTSCHLAND (ALLEMAGNE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

Details

Made byABBVIE DEUTSCHLAND (ALLEMAGNE)
Active substanceLopinavir + Ritonavir
Strength200 mg + 50 mg
Formcomprimé pelliculé
Routeorale
Dispensing (as stated by the register)prescription initiale hospitalière annuelle · liste I · renouvellement non restreint
MarketedYes, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/01/172
Name in the registerKALETRA 200 mg/50 mg, comprimé pelliculé
Packs1 flacon(s) polyéthylène haute densité (PEHD) de 120 comprimé(s) · 10 plaquette(s) PVC fluoropolymère de 12 comprimé(s)
CIS67969992
CIP133400937609937
CIP133400949409648

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.